$DAIO
DATA I/O CORP Stock $daio

$daio Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000165495421012098 Filed on November 12, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$6.357M	$6.730M	$5.947M
YoY Change	28.68%	13.17%	56.09%
Cost Of Revenue	$2.900M	$2.642M	$2.670M
YoY Change	10.69%	-1.05%	47.51%
Gross Profit	$3.457M	$4.088M	$3.277M
YoY Change	49.01%	24.75%	63.85%
Gross Profit Margin	54.38%	60.74%	55.1%
Selling, General & Admin	$2.026M	$2.216M	$1.810M
YoY Change	29.04%	22.43%	17.53%
% of Gross Profit	58.61%	54.21%	55.23%
Research & Development	$1.626M	$1.730M	$1.567M
YoY Change	2.26%	10.4%	3.77%
% of Gross Profit	47.04%	42.32%	47.82%
Depreciation & Amortization	$151.0K	$166.0K	$170.0K
YoY Change	-24.5%	-2.35%	-32.0%
% of Gross Profit	4.37%	4.06%	5.19%
Operating Expenses	$3.652M	$3.946M	$3.377M
YoY Change	15.57%	16.85%	11.09%
Operating Profit	-$195.0K	$142.0K	-$100.0K
YoY Change	-76.79%	-242.0%	-90.38%
Interest Expense	-$138.0K	$8.000K	$4.000K
YoY Change	-34.29%	100.0%	-98.4%
% of Operating Profit		5.63%
Other Income/Expense, Net		-$18.00K	-$267.0K
YoY Change		-93.26%
Pretax Income	-$312.0K	$124.0K	-$367.0K
YoY Change	-81.65%	-133.79%	-53.54%
Income Tax	-$107.0K	$112.0K	$340.0K
% Of Pretax Income		90.32%
Net Earnings	-$205.0K	$12.00K	-$707.0K
YoY Change	-87.58%	-101.7%	-15.83%
Net Earnings / Revenue	-3.22%	0.18%	-11.89%
Basic Earnings Per Share		$0.00	-$0.09
Diluted Earnings Per Share	-$23.77K	$0.00	-$0.09
COMMON SHARES
Basic Shares Outstanding	8.621M shares	8.621M shares	8.394M shares
Diluted Shares Outstanding		8.760M shares	8.394M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.19M	$14.24M	$12.98M
YoY Change	0.14%	9.71%	-14.49%
Cash & Equivalents	$14.19M	$14.24M	$12.98M
Short-Term Investments
Other Short-Term Assets	$737.0K	$518.0K	$1.730M
YoY Change	-44.12%	-70.06%	198.28%
Inventory	$6.351M	$6.050M	$5.060M
Prepaid Expenses
Receivables	$3.995M	$4.051M	$4.150M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$25.27M	$24.86M	$23.93M
YoY Change	8.7%	3.89%	1.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$946.0K	$940.0K	$2.680M
YoY Change	-22.2%	-64.93%	-21.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.838M	$1.454M	$420.0K
YoY Change	152.04%	246.19%	0.0%
Total Long-Term Assets	$3.784M	$2.394M	$3.090M
YoY Change	61.57%	-22.52%	-31.03%
TOTAL ASSETS
Total Short-Term Assets	$25.27M	$24.86M	$23.93M
Total Long-Term Assets	$3.784M	$2.394M	$3.090M
Total Assets	$29.06M	$27.25M	$27.02M
YoY Change	13.54%	0.87%	-3.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.373M	$1.527M	$1.760M
YoY Change	10.28%	-13.24%	102.3%
Accrued Expenses	$3.909M	$3.487M	$2.690M
YoY Change	38.62%	29.63%	0.37%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.789M	$6.378M	$5.650M
YoY Change	30.78%	12.88%	8.86%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$138.0K	$221.0K	$910.0K
YoY Change	-20.69%	-75.71%	-37.67%
Total Long-Term Liabilities	$138.0K	$221.0K	$910.0K
YoY Change	-20.69%	-75.71%	-37.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.789M	$6.378M	$5.650M
Total Long-Term Liabilities	$138.0K	$221.0K	$910.0K
Total Liabilities	$6.927M	$6.599M	$6.560M
YoY Change	29.11%	0.59%	-1.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.011M	-$1.806M
YoY Change	38.12%
Common Stock	$20.89M	$20.61M
YoY Change	4.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.85M	$19.71M	$20.47M
YoY Change
Total Liabilities & Shareholders Equity	$29.06M	$27.25M	$27.02M
YoY Change	13.54%	0.87%	-3.77%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$205.0K	$12.00K	-$707.0K
YoY Change	-87.58%	-101.7%	-15.83%
Depreciation, Depletion And Amortization	$151.0K	$166.0K	$170.0K
YoY Change	-24.5%	-2.35%	-32.0%
Cash From Operating Activities	$147.0K	$1.419M	-$450.0K
YoY Change	-84.85%	-415.33%	-160.81%
INVESTING ACTIVITIES
Capital Expenditures	-$262.0K	-$126.0K	-$220.0K
YoY Change	24.76%	-42.73%	144.44%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$262.0K	-$126.0K	-$220.0K
YoY Change	24.76%	-42.73%	144.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.000K	7.000K	20.00K
YoY Change		-65.0%	-108.33%
NET CHANGE
Cash From Operating Activities	147.0K	1.419M	-450.0K
Cash From Investing Activities	-262.0K	-126.0K	-220.0K
Cash From Financing Activities	1.000K	7.000K	20.00K
Net Change In Cash	-114.0K	1.300M	-650.0K
YoY Change	-115.0%	-300.0%	-258.54%
FREE CASH FLOW
Cash From Operating Activities	$147.0K	$1.419M	-$450.0K
Capital Expenditures	-$262.0K	-$126.0K	-$220.0K
Free Cash Flow	$409.0K	$1.545M	-$230.0K
YoY Change	-65.34%	-771.74%	-127.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8621007	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14241000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14167000	USD
CY2021Q3	daio	Trade Accounts Receivable Net Of Allowance TradeAccountsReceivableNetOfAllowance	84000	USD
CY2020Q4	daio	Trade Accounts Receivable Net Of Allowance TradeAccountsReceivableNetOfAllowance	66000	USD
CY2021Q3	daio	Trade Accounts Receivable Net Of Allowance For Doubtful Accounts TradeAccountsReceivableNetOfAllowanceForDoubtfulAccounts	4051000	USD
CY2020Q4	daio	Trade Accounts Receivable Net Of Allowance For Doubtful Accounts TradeAccountsReceivableNetOfAllowanceForDoubtfulAccounts	2494000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	6050000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	5270000	USD
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	518000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1319000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	24860000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	23250000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	940000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1216000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1454000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1126000	USD
CY2021Q3	us-gaap	Assets Assets	27254000	USD
CY2020Q4	us-gaap	Assets Assets	25592000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1527000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1245000	USD
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2206000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1509000	USD
CY2021Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1223000	USD
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1068000	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1281000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1307000	USD
CY2021Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	141000	USD
CY2020Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	62000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6378000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5191000	USD
CY2021Q3	daio	Operating Lease Liabilities Non OperatingLeaseLiabilitiesNon	942000	USD
CY2020Q4	daio	Operating Lease Liabilities Non OperatingLeaseLiabilitiesNon	588000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	221000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	174000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000000	shares
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8621007000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8416335000	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	20608000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	20071000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1806000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1456000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	911000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1024000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	19713000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	19639000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27254000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25592000	USD
CY2021Q3	us-gaap	Revenues Revenues	6730000	USD
CY2020Q3	us-gaap	Revenues Revenues	5947000	USD
	us-gaap	Revenues Revenues	19478000	USD
	us-gaap	Revenues Revenues	15387000	USD
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2642000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2670000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8215000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6887000	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	4088000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	3277000	USD
	us-gaap	Gross Profit GrossProfit	11263000	USD
	us-gaap	Gross Profit GrossProfit	8500000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1730000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1567000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5009000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4763000	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2216000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1810000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6332000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5324000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	3946000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	3377000	USD
	us-gaap	Operating Expenses OperatingExpenses	11341000	USD
	us-gaap	Operating Expenses OperatingExpenses	10087000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-64000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-302000	USD
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-267000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-53000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-289000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	142000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-100000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-78000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1587000	USD
CY2021Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	8000	USD
CY2020Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	4000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	11000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	13000	USD
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-26000	USD
CY2020Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-271000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	124000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-367000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-131000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1876000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	112000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	340000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	219000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	442000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	12000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-707000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-350000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8621000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8394000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8519000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8305000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8760000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8394000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8519000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8305000	shares
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	12000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-707000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-350000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2318000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-85000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	482000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-113000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	302000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-73	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-225	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-463	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2016	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	21530000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-10000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	14000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	249000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-554000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-265000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	20964000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-163000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0	USD
CY2020Q2	us-gaap	Share Based Compensation ShareBasedCompensation	481000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-1057000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	85000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	20310000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	15000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0	USD
CY2020Q3	us-gaap	Share Based Compensation ShareBasedCompensation	366000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-707000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	482000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	20466000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	19639000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-4000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	16000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	278000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-333000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-180000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	19416000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-442000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	0	USD
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	401000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-29000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	152000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	19498000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	8000	USD
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	280000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	12000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-85000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	19713000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2318000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	516000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	620000	USD
	daio	Equipment Transferred To Cost Of Goods Sold EquipmentTransferredToCostOfGoodsSold	121000	USD
	daio	Equipment Transferred To Cost Of Goods Sold EquipmentTransferredToCostOfGoodsSold	186000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	961000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1096000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1601000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-465000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	800000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-140000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	897000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	477000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	228000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-352000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-287000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1014000	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	443000	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	1074000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1263000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-342000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	361000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	654000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-361000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-654000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-424000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-144000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-424000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-144000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	478000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1140000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-404000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	186000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14167000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13936000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14241000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12982000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-463000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	338000	USD
	daio	Covidnineteen Ploicytextblock CovidnineteenPloicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2021, we have continued to react to and manage our business relative to the COVID-19 pandemic. During 2020, COVID-19 had impacted all aspects of our business, from customer demand, to supply chain integrity, employee safety, business processes, and financial management. As a global company, we had to manage each of these while working within the guidelines of local and national policy in the U.S., China and Germany. Our philosophy at the start of the outbreak was simple: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;font-variant:normal;font-weight:normal;font-style:normal;text-align:left;line-height:normal;width:100%"><tbody><tr style="height:15px"><td style="width:3%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:3%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1. </p></td><td style="vertical-align:top;">Keep our people and their families safe;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2.</p></td><td style="vertical-align:top;">Keep our facilities safe and operational while we serve our customers as an essential business; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">3. </p></td><td style="vertical-align:top;">Preserve cash.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have managed the COVID-19 impact successfully to date, with no known employee transmissions in the workplace and significant preservation of our cash and working capital. Our resilient supply chain model kept our facilities in Shanghai, China and Redmond, Washington open, and serving customers globally. We face continued international travel restrictions, shipping delays, and inability to meet with customers in person. As business has recovered we have been able to respond by having the working capital needed and the workforce in place. In the second quarter, we experienced a surge of demand as customers resumed operations and adding capacity. The backlog created by the surge resulted in the revenue growth in the third quarter. In supply chains around the world with the re-openings and now, in a believed ripple effect, factories are experiencing the impact of chip shortages on their production plans. This appears to be a shorter-term issue and the outlook by industry analysts for automotive electronics remains strong for a decade. Waves of COVID-19 infection rates and variants have kept or re-imposed revised travel restrictions. Customers largely have not permitted in-person sales and other visits. Converting these interactions to remote and virtual means has meant implementing new processes and technology. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In production, in addition to adding protective health measures for our employees, we have focused on supply chain resilience and duplicating production capability for some products in both our Shanghai, China and Redmond, USA facilities. We implemented additional supplier financial and other monitoring, as well as adding additional local suppliers and increasing inventory stock levels of key parts. Other than production employees who necessarily are onsite, most other Redmond employees are working remotely with hybrid flexibility to be onsite as desired or needed and this is expected to continue through year-end. China employees are generally onsite. We believe our exposure to COVID-19 risks are reduced by vaccination coverage, which is 98% in Redmond with our China and Germany facilities not far behind.</p>
	daio	Warranty Claims WarrantyClaims	-621000	USD
	daio	Other Commitments OtherCommitments	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>NOTE 6 – OTHER COMMITMENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have purchase obligations for inventory and production costs as well as other obligations such as capital expenditures, service contracts, marketing, and development agreements. Arrangements are considered purchase obligations if a contract specifies all significant terms, including fixed or minimum quantities to be purchased, a pricing structure and approximate timing of the transaction. Most arrangements are cancelable without a significant penalty, and with short notice, typically less than 90 days. At September 30, 2021, the purchase commitments and other obligations totaled $2.1 million of which all but $58,000 are expected to be paid over the next twelve months.</p>
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	139	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	69	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	57	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12500	shares

Files In Submission

Name	View Source	Status
0001654954-21-012098-index-headers.html	Edgar Link	pending
0001654954-21-012098-index.html	Edgar Link	pending
0001654954-21-012098.txt	Edgar Link	pending
0001654954-21-012098-xbrl.zip	Edgar Link	pending
daio-20210930.xsd	Edgar Link	pending
daio-20210930_cal.xml	Edgar Link	unprocessable
daio-20210930_def.xml	Edgar Link	unprocessable
daio-20210930_lab.xml	Edgar Link	unprocessable
daio-20210930_pre.xml	Edgar Link	unprocessable
daio_10q.htm	Edgar Link	pending
daio_10q_htm.xml	Edgar Link	completed
daio_ex311.htm	Edgar Link	pending
daio_ex312.htm	Edgar Link	pending
daio_ex321.htm	Edgar Link	pending
daio_ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DAIO
DATA I/O CORP Stock $daio

2021 Q4 Form 10-Q Financial Statement

#000165495421012098 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DAIO DATA I/O CORP Stock $daio

2021 Q4 Form 10-Q Financial Statement

#000165495421012098 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DAIO
DATA I/O CORP Stock $daio